A WHO study across 17 countries found that the gateway drug sequence (tobacco/alcohol to cannabis to other drugs) partially reflects common causes like drug availability rather than causal effects of earlier drugs promoting later use.
Read this if you have heard that cannabis is a gateway drug and want to see what international data actually show.
17 countries: gateway sequence varied with drug prevalence, suggesting common causes, not causation
What the researchers found
Using data from WHO World Mental Health Surveys across 17 countries with widely varying drug use prevalence, researchers tested whether the standard gateway sequence (alcohol/tobacco to cannabis to other illicit drugs) reflects a causal chain or other factors.
The likelihood of progression from "gateway" substances to other illicit drugs varied based on the background prevalence of gateway substance use in each country. In countries where gateway substances were more commonly used, the conditional probability of progression was different.
Cross-country differences in substance use prevalence also corresponded to differences in the likelihood of non-normative sequences (people starting with "harder" drugs before "softer" ones).
The authors concluded that the gateway pattern at least partially reflects unmeasured common causes (like drug availability, cultural attitudes, and socioeconomic factors) rather than causal effects of specific drugs promoting subsequent use.
The implication: preventing use of specific gateway drugs may not lead to major reductions in later drug use.
Why it matters
The gateway theory has profoundly influenced drug policy for decades. This large cross-national study provided evidence that the theory oversimplifies the relationship between substance use progression, suggesting policy should focus on common underlying causes rather than specific gateway substances.
The numbers in context
17 countries surveyed. Initiation sequence varied with background substance use prevalence. Non-normative sequences (skipping gateway drugs) were more common in some countries.
How the study worked
Cross-national analysis using WHO World Mental Health Surveys conducted in 17 countries with consistent instruments and procedures. Patterns and order of initiation of alcohol, tobacco, cannabis, and other illicit drug use were compared across populations with varying drug prevalence.
What this study cannot tell us
Cross-sectional surveys rely on retrospective recall of drug initiation timing. The study could not directly test causal mechanisms. "Common causes" were inferred from patterns rather than measured directly.
How to read the evidence
Large cross-national study using standardized WHO survey methodology across diverse populations. Strong design for testing the gateway hypothesis, though unable to directly measure causal mechanisms.
When this study was published
Published in 2010. The gateway theory remains debated, but most researchers now agree that common underlying factors play a larger role than any causal chain between specific substances.
The bigger picture
Drug policy based on the gateway theory focuses on preventing initial cannabis use to prevent later hard drug use. If the gateway sequence reflects shared causes rather than causal chains, this policy approach may be misguided, and resources might be better directed at addressing underlying risk factors.
Questions still open
- What are the common causes that drive the gateway sequence? Would addressing poverty, mental health, or drug availability be more effective than preventing cannabis use? Does the gateway theory hold for any substance-to-substance transition?
Common questions
Is cannabis a gateway drug?
What are the "common causes" the study refers to?
Read the original research
Evaluating the drug use "gateway" theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys.
Drug and alcohol dependence, 108(1-2), 84-97
Citation
Degenhardt, Louisa; Dierker, Lisa; Chiu, Wai Tat; Medina-Mora, Maria Elena; Neumark, Yehuda; Sampson, Nancy; Alonso, Jordi; Angermeyer, Matthias; Anthony, James C; Bruffaerts, Ronny; de Girolamo, Giovanni; de Graaf, Ron; Gureje, Oye; Karam, Aimee N; Kostyuchenko, Stanislav; Lee, Sing; Lépine, Jean-Pierre; Levinson, Daphna; Nakamura, Yosikazu; Posada-Villa, Jose; Stein, Dan; Wells, J Elisabeth; Kessler, Ronald C. (2010). Evaluating the drug use "gateway" theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys.. Drug and alcohol dependence, 108(1-2), 84-97. https://doi.org/10.1016/j.drugalcdep.2009.12.001
Explore the wider topic
- Physical vs Psychological Cannabis Dependence: What Science Actually Shows
- The Gap Between Cannabis Perception and Science: Why What We Believe Outpaces What We Know
- Cannabis Use Disorder: Am I Addicted? Self-Assessment Guide
- Cross-Addiction After Quitting Weed: When One Habit Replaces Another
- Is Weed Addictive? What the Research Actually Shows
- Is Cannabis Addictive? What the DSM-5 and Brain Science Say
- Quitting Weed and Alcohol Together: What to Know About Dual Cessation
- Is Rehab Necessary for Weed? An Honest Assessment
- Signs You May Have Cannabis Use Disorder: An Honest Self-Assessment
- Weed Vape Pen Addiction: Why Vaping Makes It Harder to Quit